{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:16:42Z","timestamp":1792790202764,"version":"4.5.0"},"reference-count":50,"publisher":"American Association for the Advancement of Science (AAAS)","funder":[{"name":"National Research Foundation (NRF) of Korea Grant","award":["NRF-2023R1A2C2006414"],"award-info":[{"award-number":["NRF-2023R1A2C2006414"]}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Biomater Res"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>\n                    Cerebral ischemia impairs blood circulation, leading to elevated reactive oxygen species (ROS) production. A ROS-responsive delivery of drugs can enhance the therapeutic efficacy and minimize the side effects. There is insufficient evidence on the impact of ROS-responsive nanoparticles on ischemic stroke. We developed ROS-responsive chitosan\u2013bilirubin (ChiBil) nanoparticles to target acute ischemic lesions and investigated the effect of atorvastatin-loaded ROS-responsive ChiBil. We randomly assigned rats with transient middle cerebral artery occlusion (MCAO) to 4 groups: saline, Statin, ChiBil, and ChiBil-Statin. These groups were treated daily via the tail vein for 7 d. Behavioral assessment, magnetic resonance (MR) imaging, evaluation of neuroinflammation, blood\u2013brain barrier (BBB) integrity, apoptosis, and neurogenesis after stroke were conducted. In\u00a0vitro, results showed nanoparticle uptake and reduced intracellular ROS, lipid peroxidation, and inflammatory cytokines (IL-6 and TNF-\u03b1). In\u00a0vivo, results showed improved motor deficits and decreased infarct volumes on MR images in the ChiBil-Statin group compared with the Control group on day 7 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.05). Furthermore, the expression of inflammatory cytokines such as IL-1\u03b2 and IL-6 was reduced in the ChiBil-Statin group compared with the Control group (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.05). Improvements in BBB integrity, apoptosis, and neurogenesis were observed in the ChiBil-Statin group. The findings demonstrated that intravenous ROS-responsive multifunctional ChiBil-Statin could effectively deliver drugs to the ischemic brain, exerting marked synergistic pleiotropic neuroprotective effects. Therefore, ChiBil-Statin holds promise as a targeted therapy for ischemic vascular diseases characterized by increased ROS production, leading to new avenues for future research and potential clinical applications.\n                  <\/jats:p>","DOI":"10.34133\/bmr.0097","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T09:19:57Z","timestamp":1728811197000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Reactive Oxygen Species-Responsive Chitosan\u2013Bilirubin Nanoparticles Loaded with Statin for Treatment of Cerebral Ischemia"],"prefix":"10.34133","volume":"28","author":[{"family":"Raveena Nagareddy","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, \rChonnam National University Medical School and Hwasun Hospital, Hwasun, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Hae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, \rChonnam National University Medical School and Hospital, Gwangju, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hye","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, \rChonnam National University Medical School and Hospital, Gwangju, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reju George","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Radiology, \rChonnam National University Medical School and Hwasun Hospital, Hwasun, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8851-2104","authenticated-orcid":true,"given":"Kang-Ho","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Neurology, \rChonnam National University Medical School and Hospital, Gwangju, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Yeon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Radiology, \rChonnam National University Medical School and Hwasun Hospital, Hwasun, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"issue":"3","key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers WJ","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49(3):e46\u2013e110.","journal-title":"Stroke"},{"issue":"10029","key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal M","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Davalos A, Majoie CB, van der Lugt A, de Miquel MA, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723\u20131731.","journal-title":"Lancet"},{"issue":"6","key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/neuros\/nyx341","article-title":"Cerebral ischemic reperfusion injury following recanalization of large vessel occlusions","volume":"82","author":"Al-Mufti F","year":"2018","unstructured":"Al-Mufti F, Amuluru K, Roth W, Nuoman R, El-Ghanem M, Meyers PM. Cerebral ischemic reperfusion injury following recanalization of large vessel occlusions. Neurosurgery. 2018;82(6):781\u2013789.","journal-title":"Neurosurgery"},{"issue":"6","key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.STR.27.6.1124","article-title":"Role of oxidants in ischemic brain damage","volume":"27","author":"Chan PH","year":"1996","unstructured":"Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996;27(6):1124\u20131129.","journal-title":"Stroke"},{"issue":"1","key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00221-007-1050-9","article-title":"Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke","volume":"182","author":"Saeed SA","year":"2007","unstructured":"Saeed SA, Shad KF, Saleem T, Javed F, Khan MU. Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp Brain Res. 2007;182(1):1\u201310.","journal-title":"Exp Brain Res"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"116186","DOI":"10.1016\/j.bcp.2024.116186","article-title":"The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials","volume":"228","author":"Lochhead JJ","year":"2024","unstructured":"Lochhead JJ, Ronaldson PT, Davis TP. The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials. Biochem Pharmacol. 2024;228:116186.","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"e_1_3_3_8_2","first-page":"37","article-title":"Oxidative stress in the pathogenesis of stroke","volume":"21","author":"Lutskii MA","year":"2007","unstructured":"Lutskii MA, Esaulenko IE, Tonkikh RV, Anibal AP. Oxidative stress in the pathogenesis of stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2007;21(Suppl 21):37\u201342.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"3","key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/btm2.10014","article-title":"ROS-responsive drug delivery systems","volume":"1","author":"Liang J","year":"2016","unstructured":"Liang J, Liu B. ROS-responsive drug delivery systems. Bioeng Transl Med. 2016;1(3):239\u2013251.","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"1600124","DOI":"10.1002\/advs.201600124","article-title":"Reactive-oxygen-species-responsive drug delivery systems: Promises and challenges","volume":"4","author":"Saravanakumar G","year":"2017","unstructured":"Saravanakumar G, Kim J, Kim WJ. Reactive-oxygen-species-responsive drug delivery systems: Promises and challenges. Adv Sci. 2017;4(1):1600124.","journal-title":"Adv Sci"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.actbio.2020.09.014","article-title":"A bilirubin-conjugated chitosan nanotheranostics system as a platform for reactive oxygen species stimuli-responsive hepatic fibrosis therapy","volume":"116","author":"Surendran SP","year":"2020","unstructured":"Surendran SP, Thomas RG, Moon MJ, Park R, Lee JH, Jeong YY. A bilirubin-conjugated chitosan nanotheranostics system as a platform for reactive oxygen species stimuli-responsive hepatic fibrosis therapy. Acta Biomater. 2020;116:356\u2013367.","journal-title":"Acta Biomater"},{"issue":"12","key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1021\/acsapm.3c02034","article-title":"Proline-loaded chitosan nanoparticles penetrate the blood\u2013brain barrier to confer neuroprotection in mice cerebral ischemia injury","volume":"5","author":"Gao J","year":"2023","unstructured":"Gao J, Wang X, Kong X, Yao X, Ren J, Chen S, Shen N, Li Z, Wang Y, Wei Y, et al. Proline-loaded chitosan nanoparticles penetrate the blood\u2013brain barrier to confer neuroprotection in mice cerebral ischemia injury. ACS Appl Polymer Mater. 2023;5(12):10234\u201310244.","journal-title":"ACS Appl Polymer Mater"},{"issue":"6","key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1007\/s12035-015-9333-9","article-title":"Enhanced neuroprotection of Acetyl-11-keto-\u03b2-boswellic acid(AKBA)-loaded O-carboxymethyl chitosan nanoparticles through antioxidant and anti-inflammatory pathways","volume":"53","author":"Ding Y","year":"2016","unstructured":"Ding Y, Qiao Y, Wang M, Zhang H, Li L, Zhang Y, Ge J, Song Y, Li Y, Wen A. Enhanced neuroprotection of Acetyl-11-keto-\u03b2-boswellic acid(AKBA)-loaded O-carboxymethyl chitosan nanoparticles through antioxidant and anti-inflammatory pathways. Mol Neurobiol. 2016;53(6):3842\u20133853.","journal-title":"Mol Neurobiol"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijbiomac.2016.06.001","article-title":"Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia","volume":"91","author":"Ahmad N","year":"2016","unstructured":"Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, Iqbal Z, Ahmad FJ. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia. Int J Biol Macromol. 2016;91:640\u2013655.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"e_1_3_3_15_2","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000914","article-title":"Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications","volume":"5","author":"DiNicolantonio JJ","year":"2018","unstructured":"DiNicolantonio JJ, McCarty MF, O\u2019Keefe JH. Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications. Open Heart. 2018;5(2): Article e000914.","journal-title":"Open Heart"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201604858"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jconrel.2020.08.054","article-title":"Therapeutic application and construction of bilirubin incorporated nanoparticles","volume":"328","author":"Yao Q","year":"2020","unstructured":"Yao Q, Chen R, Ganapathy V, Kou L. Therapeutic application and construction of bilirubin incorporated nanoparticles. J Control Release. 2020;328:407\u2013424.","journal-title":"J Control Release"},{"issue":"4","key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12975-019-00750-7","article-title":"Statin therapy in ischemic stroke models: A meta-analysis","volume":"11","author":"Christophe B","year":"2020","unstructured":"Christophe B, Karatela M, Sanchez J, Pucci J, Connolly ES. Statin therapy in ischemic stroke models: A meta-analysis. Transl Stroke Res. 2020;11(4):590\u2013600.","journal-title":"Transl Stroke Res"},{"issue":"2","key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12975-023-01125-9","article-title":"Treatment of ischemic stroke by atorvastatin-loaded PEGylated liposome","volume":"15","author":"Thomas RG","year":"2023","unstructured":"Thomas RG, Kim JH, Kim JH, Yoon J, Choi KH, Jeong YY. Treatment of ischemic stroke by atorvastatin-loaded PEGylated liposome. Transl Stroke Res. 2023;15(2):388\u2013398.","journal-title":"Transl Stroke Res"},{"issue":"5","key":"e_1_3_3_20_2","first-page":"H2210","article-title":"Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke","volume":"291","author":"Hong H","year":"2006","unstructured":"Hong H, Zeng J-S, Kreulen DL, Kaufman DI, Chen AF. Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am J Phys Heart Circ Phys. 2006;291(5):H2210\u2013H2215.","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"2","key":"e_1_3_3_21_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lfs.2013.11.018","article-title":"Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats","volume":"94","author":"Saito T","year":"2014","unstructured":"Saito T, Nito C, Ueda M, Inaba T, Kamiya F, Muraga K, Katsura K-I, Katayama Y. Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats. Life Sci. 2014;94(2):106\u2013114.","journal-title":"Life Sci"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2015.07.013","article-title":"Neuroprotective effects and dynamic expressions of MMP9 and TIMP1 associated with atorvastatin pretreatment in ischemia\u2013reperfusion rats","volume":"603","author":"Fang X","year":"2015","unstructured":"Fang X, Tao D, Shen J, Wang Y, Dong X, Ji X. Neuroprotective effects and dynamic expressions of MMP9 and TIMP1 associated with atorvastatin pretreatment in ischemia\u2013reperfusion rats. Neurosci Lett. 2015;603:60\u201365.","journal-title":"Neurosci Lett"},{"issue":"9","key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.3390\/ijms22094385","article-title":"The effects of atorvastatin on global cerebral ischemia-induced neuronal death","volume":"22","author":"Kho AR","year":"2021","unstructured":"Kho AR, Hong DK, Kang BS, Park WJ, Choi KC, Park KH, Suh SW. The effects of atorvastatin on global cerebral ischemia-induced neuronal death. Int J Mol Sci. 2021;22(9):4385.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11936-012-0174-9","article-title":"Neuroprotective effects of statins: Evidence from preclinical and clinical studies","volume":"14","author":"Fisher M","year":"2012","unstructured":"Fisher M, Moonis M. Neuroprotective effects of statins: Evidence from preclinical and clinical studies. Curr Treat Options Cardiovasc Med. 2012;14(3):252\u2013259.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"1","key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle A","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120(1):229\u2013243.","journal-title":"Circ Res"},{"issue":"1","key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"18472","DOI":"10.1038\/s41598-023-45858-x","article-title":"Preparation, characterization and in\u00a0vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles","volume":"13","author":"Du L","year":"2023","unstructured":"Du L, Lu H, Xiao Y, Guo Z, Li Y. Preparation, characterization and in\u00a0vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles. Sci Rep. 2023;13(1):18472.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s42004-023-01043-9","article-title":"Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies","volume":"6","author":"Wu Y","year":"2023","unstructured":"Wu Y, Angelov B, Deng Y, Fujino T, Hossain MS, Drechsler M, Angelova A. Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies. Commun Chem. 2023;6(1):241.","journal-title":"Commun Chem"},{"issue":"1","key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13041-015-0101-6","article-title":"Alpha-lipoic acid treatment is neurorestorative and promotes functional recovery after stroke in rats","volume":"8","author":"Choi K-H","year":"2015","unstructured":"Choi K-H, Park M-S, Kim H-S, Kim K-T, Kim H-S, Kim J-T, Kim B-C, Kim M-K, Park J-T, Cho K-H. Alpha-lipoic acid treatment is neurorestorative and promotes functional recovery after stroke in rats. Mol Brain. 2015;8(1):9.","journal-title":"Mol Brain"},{"issue":"5","key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/STROKEAHA.116.013205","article-title":"Regulation of caveolin-1 expression determines early brain edema after experimental focal cerebral ischemia","volume":"47","author":"Choi KH","year":"2016","unstructured":"Choi KH, Kim HS, Park MS, Kim JT, Kim JH, Cho KA, Lee MC, Lee HJ, Cho KH. Regulation of caveolin-1 expression determines early brain edema after experimental focal cerebral ischemia. Stroke. 2016;47(5):1336\u20131343.","journal-title":"Stroke"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fchem.2020.00732","article-title":"Reactive oxygen species(ROS)-responsive nanomedicine for solving ischemia-reperfusion injury","volume":"8","author":"Chen W","year":"2020","unstructured":"Chen W, Li D. Reactive oxygen species(ROS)-responsive nanomedicine for solving ischemia-reperfusion injury. Front Chem. 2020;8:732.","journal-title":"Front Chem"},{"issue":"1","key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12951-024-02673-4","article-title":"Polymeric nanocarriers delivery systems in ischemic stroke for targeted therapeutic strategies","volume":"22","author":"Zhu L","year":"2024","unstructured":"Zhu L, Zhong W, Meng X, Yang X, Zhang W, Tian Y, Li Y. Polymeric nanocarriers delivery systems in ischemic stroke for targeted therapeutic strategies. J Nanobiotechnology. 2024;22(1):424.","journal-title":"J Nanobiotechnology"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.10.020"},{"issue":"30","key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1039\/C8TB00022K","article-title":"Novel iron oxide-cerium oxide core-shell nanoparticles as a potential theranostic material for ROS related inflammatory diseases","volume":"6","author":"Wu Y","year":"2018","unstructured":"Wu Y, Yang Y, Zhao W, Xu ZP, Little PJ, Whittaker AK, Zhang R, Ta HT. Novel iron oxide-cerium oxide core-shell nanoparticles as a potential theranostic material for ROS related inflammatory diseases. J Mater Chem B. 2018;6(30):4937\u20134951.","journal-title":"J Mater Chem B"},{"issue":"5","key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1021\/acsnano.2c11363","article-title":"Reactive oxygen species-responsive transformable and triple-targeting butylphthalide nanotherapy for precision treatment of ischemic stroke by normalizing the pathological microenvironment","volume":"17","author":"Yang Q","year":"2023","unstructured":"Yang Q, Pu W, Hu K, Hu Y, Feng Z, Cai J, Li C, Li L, Zhou Z, Zhang J. Reactive oxygen species-responsive transformable and triple-targeting butylphthalide nanotherapy for precision treatment of ischemic stroke by normalizing the pathological microenvironment. ACS Nano. 2023;17(5):4813\u20134833.","journal-title":"ACS Nano"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113010"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.12.029"},{"issue":"8","key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.2042-7158.2011.01273.x","article-title":"Statins therapy: A review on conventional and novel formulation approaches","volume":"63","author":"Tiwari R","year":"2011","unstructured":"Tiwari R, Pathak K. Statins therapy: A review on conventional and novel formulation approaches. J Pharm Pharmacol. 2011;63(8):983\u2013998.","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"e_1_3_3_38_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2020.01.042","article-title":"Intravenous statin administration during myocardial infarction compared with oral post-infarct administration","volume":"75","author":"Mendieta G","year":"2020","unstructured":"Mendieta G, Ben-Aicha S, Gutierrez M, Casani L, Arzanauskaite M, Carreras F, Sabate M, Badimon L, Vilahur G. Intravenous statin administration during myocardial infarction compared with oral post-infarct administration. J Am Coll Cardiol. 2020;75(12):1386\u20131402.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00136.2018"},{"key":"e_1_3_3_40_2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.594672","article-title":"Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery","volume":"11","author":"Bernardo-Castro S","year":"2020","unstructured":"Bernardo-Castro S, Sousa JA, Br\u00e1s A, Cec\u00edlia C, Rodrigues B, Almendra L, Machado C, Santo G, Silva F, Ferreira L, et al. Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol. 2020;11: Article 594672.","journal-title":"Front Neurol"},{"issue":"2","key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuint.2011.11.009","article-title":"Reactive oxygen species and ischemic cerebrovascular disease","volume":"60","author":"Olmez I","year":"2012","unstructured":"Olmez I, Ozyurt H. Reactive oxygen species and ischemic cerebrovascular disease. Neurochem Int. 2012;60(2):208\u2013212.","journal-title":"Neurochem Int"},{"issue":"6","key":"e_1_3_3_42_2","doi-asserted-by":"crossref","first-page":"175909141455841","DOI":"10.1177\/1759091414558417","article-title":"Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats","volume":"6","author":"Lei S","year":"2014","unstructured":"Lei S, Zhang P, Li W, Gao M, He X, Zheng J, Li X, Wang X, Wang N, Zhang J, et al. Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats. ASN Neuro. 2014;6(6):1759091414558417.","journal-title":"ASN Neuro"},{"issue":"48","key":"e_1_3_3_43_2","doi-asserted-by":"crossref","first-page":"45188","DOI":"10.1021\/acsomega.3c06228","article-title":"Recent advances in chemically engineered nanostructures impact on ischemic stroke treatment","volume":"8","year":"2023","unstructured":"Recent advances in chemically engineered nanostructures impact on ischemic stroke treatment. ACS Omega. 2023;8(48):45188\u201345207.","journal-title":"ACS Omega"},{"key":"e_1_3_3_44_2","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.2147\/IJN.S462194","article-title":"Innovations in breaking barriers: Liposomes as near-perfect drug carriers in ischemic stroke therapy","volume":"19","author":"Zhang Q","year":"2024","unstructured":"Zhang Q, Huang S, Liu X, Wang W, Zhu Z, Chen L. Innovations in breaking barriers: Liposomes as near-perfect drug carriers in ischemic stroke therapy. Int J Nanomedicine. 2024;19:3715\u20133735.","journal-title":"Int J Nanomedicine"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S68861"},{"issue":"2","key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12028-024-01994-4","article-title":"The effects of IRL-1620 in post-ischemic brain injury: A systematic review and meta-analysis of experimental studies","volume":"41","author":"Moustakas D","year":"2024","unstructured":"Moustakas D, Mani I, Pouliakis A, Iacovidou N, Xanthos T. The effects of IRL-1620 in post-ischemic brain injury: A systematic review and meta-analysis of experimental studies. Neurocrit Care. 2024;41(2):665\u2013680.","journal-title":"Neurocrit Care"},{"issue":"1","key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12951-022-01450-5","article-title":"Advances of nano drug delivery system for the theranostics of ischemic stroke","volume":"20","author":"Lv W","year":"2022","unstructured":"Lv W, Liu Y, Li S, Lv L, Lu H, Xin H. Advances of nano drug delivery system for the theranostics of ischemic stroke. J Nanobiotechnology. 2022;20(1):248.","journal-title":"J Nanobiotechnology"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0090-8"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030780"},{"issue":"1","key":"e_1_3_3_50_2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/ijms24010787","article-title":"Nanoparticles in clinical trials: Analysis of clinical trials, FDA approvals and use for COVID-19 vaccines","volume":"24","author":"Namiot ED","year":"2023","unstructured":"Namiot ED, Sokolov AV, Chubarev VN, Tarasov VV, Schioth HB. Nanoparticles in clinical trials: Analysis of clinical trials, FDA approvals and use for COVID-19 vaccines. Int J Mol Sci. 2023;24(1):787.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.2147\/IJN.S433756","article-title":"Key fabrications of chitosan nanoparticles for effective drug delivery using flow chemistry reactors","volume":"18","author":"Huanbutta K","year":"2023","unstructured":"Huanbutta K, Sriamornsak P, Suwanpitak K, Klinchuen N, Deebugkum T, Teppitak V, Sangnim T. Key fabrications of chitosan nanoparticles for effective drug delivery using flow chemistry reactors. Int J Nanomedicine. 2023;18:7889\u20137900.","journal-title":"Int J Nanomedicine"}],"container-title":["Biomaterials Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/bmr.0097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:02:49Z","timestamp":1729746169000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/bmr.0097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"alternative-id":["10.34133\/bmr.0097"],"URL":"https:\/\/doi.org\/10.34133\/bmr.0097","relation":{},"ISSN":["2055-7124"],"issn-type":[{"value":"2055-7124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2024-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0097"}}